EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Harnessing natural killer cell effector function against cancer

Matthew D Blunt iD, Salim I Khakoo

Immunotherapy Advances · 01.01.2024 · 4 (1)

DOI: 10.1093/immadv/ltad031 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunotherapy Advances, online erschienen am 21.12.2023. Verfasst von Matthew D Blunt und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells are cytotoxic innate lymphoid cells that participate in anti-tumour and anti-viral immune responses. Their ability to rapidly destroy abnormal cells and to enhance the anti-cancer function of dendritic cells, CD8+ T cells, and macrophages makes them an attractive target for immunotherapeutic strategies. The development of approaches that augment NK-cell activation against cancer is currently under intense preclinical and clinical research and strategies include chimeric antigen receptor NK cells, NK-cell engagers, cytokines, and immune checkpoint inhibitors. In this review, we highlight recent advances in NK-cell therapeutic development and discuss their potential to add to our armamentarium against cancer.

Schlagwörter

Stichwörter der Autor:innen

CAR-NK cellsNK-cell engagerscancerchimeric antigen receptor (CAR)immunotherapynatural killer cells (NK cells)

Autor:innen und Institutionen

  • School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

ORCID-Profile: Matthew D Blunt

Förderung

  • Cancer Research UK
  • Medical Research Council

Zitieren

APA

Blunt, M. D., & Khakoo, S. I. (2024). Harnessing natural killer cell effector function against cancer. Immunotherapy Advances, 4(1). https://doi.org/10.1093/immadv/ltad031

Vancouver

Blunt MD, Khakoo SI. Harnessing natural killer cell effector function against cancer. Immunotherapy Advances. 2024;4(1). doi:10.1093/immadv/ltad031

BibTeX
@article{Blunt2024,
  author = {Blunt, Matthew D and Khakoo, Salim I},
  title = {Harnessing natural killer cell effector function against cancer},
  journal = {Immunotherapy Advances},
  year = {2024},
  volume = {4},
  number = {1},
  doi = {10.1093/immadv/ltad031}
}
Kostenlos starten →